Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.49
+0.04 (0.62%)
Apr 29, 2026, 9:48 AM EDT - Market open

Harvard Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
293092228115288
Upgrade
Market Cap Growth
66.31%-67.60%-59.70%97.92%-59.89%72.07%
Upgrade
Enterprise Value
6566133268167336
Upgrade
Last Close Price
6.456.6921.1053.5027.7070.50
Upgrade
Forward PE
34.167.8717.5823.2617.8722.03
Upgrade
PS Ratio
0.340.340.982.041.022.42
Upgrade
PB Ratio
2.102.171.453.131.603.45
Upgrade
P/FCF Ratio
5.325.45-18.66-4294.24
Upgrade
P/OCF Ratio
4.324.4363.9116.28100.17227.98
Upgrade
PEG Ratio
-1.031.031.031.031.03
Upgrade
EV/Sales Ratio
0.750.761.422.391.482.83
Upgrade
EV/EBITDA Ratio
8.708.8454.6428.2770.1529.73
Upgrade
EV/EBIT Ratio
43.2343.91-107.55-91.12
Upgrade
EV/FCF Ratio
11.8412.02-21.92-5018.20
Upgrade
Debt / Equity Ratio
3.223.220.700.590.750.68
Upgrade
Debt / EBITDA Ratio
4.534.539.673.7012.094.24
Upgrade
Debt / FCF Ratio
8.098.09-3.51-850.15
Upgrade
Net Debt / Equity Ratio
2.602.600.640.480.690.59
Upgrade
Net Debt / EBITDA Ratio
4.794.7916.593.7120.874.34
Upgrade
Net Debt / FCF Ratio
6.526.52-33.632.88-113.55733.42
Upgrade
Asset Turnover
0.840.840.710.790.740.75
Upgrade
Inventory Turnover
1.661.661.641.791.892.06
Upgrade
Quick Ratio
1.121.120.350.770.911.17
Upgrade
Current Ratio
2.202.200.821.852.202.43
Upgrade
Return on Equity (ROE)
-147.13%-147.13%-18.19%-4.70%-12.23%-0.36%
Upgrade
Return on Assets (ROA)
0.91%0.91%-2.23%1.10%-2.11%1.45%
Upgrade
Return on Capital Employed (ROCE)
2.60%2.60%-6.60%2.30%-4.30%2.70%
Upgrade
Earnings Yield
-194.91%-190.17%-13.48%-1.49%-8.25%-0.10%
Upgrade
FCF Yield
18.81%18.35%-1.31%5.36%-0.38%0.02%
Upgrade
Buyback Yield / Dilution
-1.96%-1.96%-2.64%-2.43%-2.65%-4.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.